Diplomat receives limited distribution contract for IMBRUVICA™ (ibrutinib)

 
FLINT, Mich. - Nov. 14, 2013 - PRLog -- Flint, Mich. –Nov.  14, 2013 --- Diplomat, the country’s largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA™ (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration (FDA) for the treatment of Mantle Cell Lymphoma (MCL).

IMBRUVICA™, a Brutton’s Tyrosine Kinase (BTK) Inhibitor, is an oral drug available in 140 mg, 90 capsule bottles and 140 mg, 120 capsule bottles. Full prescribing information is available at www.IMBRUVICA.com.

“We are pleased to partner with Pharmacyclics and Janssen Biotech, Inc. as a specialty pharmacy provider of IMBRUVICA™,” said Gary Kadlec, R.Ph., President of Diplomat. “Diplomat has proven expertise in handling limited distribution drugs and an industry-wide reputation for comprehensive patient care outreach that improves patient compliance, adherence and outcomes.”

Diplomat’s high-tech, high-touch approach, which achieved 98% patient and prescriber satisfaction ratings in 2012, includes timely prescription delivery, side effect management support and 24 hour access to pharmacists and other specialists on the continuum of care. For IMBRUVICA™, Diplomat will also provide prior authorization management, co-pay support, and assistance to patients that meet certain financial criteria.

IMBRUVICA™ is commercially available immediately.

About Diplomat

Diplomat serves patients and physicians in all 50 states as the nation’s largest independent specialty pharmacy. Headquartered in Flint, Mich., the company focuses on medication management programs for people with specialized or long-term medical needs, including cancer, HIV and multiple sclerosis. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues — always focused on increasing adherence and improving outcomes. Diplomat is accredited by URAC, PCAB, VAWD, ASHP and ACHC. Learn more at diplomatpharmacy.com (http://www.diplomatpharmacy.com/).

Media Contact
Diplomat
***@diplomatpharmacy.com
877.977.9118
End
Source: » Follow
Email:***@diplomatpharmacy.com Email Verified
Tags:Limited Distribution, Imbruvica, Speciality Pharmacy, Oncology, Mantle Cell Lymphoma
Industry:Biotech, Medical
Location:Flint - Michigan - United States
Subject:Partnerships
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share